Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.48 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | XIAP | P98170 | 1/20 | 0.48 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5678777 | 1.00 | EPHX1 (0.52) | EPHX1TRPA1SRRSLC1A3SLC1A2 | |
| SCHEMBL7472546 | 1.00 | EPHX1 (0.52) | EPHX1TRPA1SRRSLC1A3SLC1A2 | |
| Hydrochloric Acid SCHEMBL7814124 | 0.98 | SRR (0.50) | EPHX1TRPA1SRRSLC1A3SLC1A2 | |
| Sulfuric Acid SCHEMBL5465230 | 0.90 | TRPA1 (0.46) | EPHX1TRPA1SRRSLC1A3SLC1A2 | |
| SCHEMBL1833635 | 0.85 | TRPA1 (0.55) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL11387865 | 0.82 | SLC6A4 (0.59) | EPHX1TRPA1SRRSLC1A3SLC1A2 | |
| SCHEMBL25152953 | 0.82 | MAOB (0.60) | PTGS1SLC6A2MAOASLC6A3CYP1A2 | |
| SCHEMBL29162424 | 0.82 | MAOB (0.60) | PTGS1SLC6A2MAOASLC6A3CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL29021310 | 0.82 | TRPA1 (0.53) | EPHX1TRPA1SRRALPIPKM | |
| SCHEMBL8357017 | 0.82 | EPHX1 (0.48) | EPHX1TRPA1SRRALPIPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119390592-A | Method for catalytic synthesis of chiral amino alcohol compound and pyrazine compound by chemical-enzyme cascade method | 南京工业大学 | 2025-02-07 | — | — | CN | claimed |
| EP-4380942-A1 | NOVEL APPLICATIONS FOR OXAZABOROLIDINES AND NEW METHODS OF MANUFACTURE THEREOF | Pathway Intermediates Limited (GB) | 2024-06-12 | — | — | EP | claimed |
| CN-117736399-A | Bio-based polyurethane foam based on lignin oligomer and vegetable oil and preparation method thereof | 中国林业科学研究院林产化学工业研究所 | 2024-03-22 | — | — | CN | claimed |
| CN-115999335-A | Flue gas desulfurizing agent and preparation method thereof | 河北冀隅智能科技有限公司 | 2023-04-25 | — | — | CN | claimed |
| WO-2023011857-A1 | NOVEL APPLICATIONS FOR OXAZABOROLIDINES AND NEW METHODS OF MANUFACTURE THEREOF | PATHWAY INTERMEDIATES LIMITED (GB) | 2023-02-09 | — | — | WO | claimed |
| WO-2022257197-A1 | APPLICATION OF AMINE COMPOUND IN REMOVING ORGANIC SULFIDES | 华东理工大学 | 2022-12-15 | — | — | WO | claimed |
| CN-114213355-A | Production process of aprepitant key intermediate | 苏州诚和医药化学有限公司 | 2022-03-22 | — | — | CN | claimed |
| CN-113289458-A | Application of amine compound in removing organic sulfide | 华东理工大学 | 2021-08-24 | — | — | CN | claimed |
| EP-2508591-B1 | WATER-SOLUBLE METALWORKING OIL AGENT AND USAGE THEREOF | IDEMITSU KOSAN CO (JP) | 2020-09-09 | — | — | EP | claimed |
| EP-3421794-B1 | REFRIGERATION APPARATUS | DAIKIN IND LTD (JP) | 2020-08-05 | — | — | EP | claimed |
| US-8293693-B2 | Conductive lubricant composition | IDEMITSU KOSAN CO., LTD. (JP) | 2012-10-23 | — | — | US | claimed |
| US-20050085668-A1 | Diols formed by ring-opening of epoxies | THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY | 2005-04-21 | — | — | US | claimed |
| WO-2004067493-A1 | DIOLS FORMED BY RING-OPENING OF EPOXIES | VERBORGT JOZEF (US) | 2004-08-12 | — | — | WO | claimed |
| US-20040143086-A1 | Diols formed by ring-opening of epoxies | THE GOVERNMENT OF THE UNITED STATES, AS RESPRESENTED BY THE SECRETARY OF THE NAVY | 2004-07-22 | — | — | US | claimed |
| EP-0914332-B1 | ISOQUINOLINES USEFUL AS ANALGESICS | ASTRAZENECA AB (SE) | 2002-05-08 | — | — | EP | claimed |
| WO-2001002355-A2 | INDOLE SYNTHESIS | AXYS PHARMACEUTICALS, INC. (US) | 2001-01-11 | — | — | WO | claimed |
| EP-0883610-B1 | PROCESS FOR PREPARING 1,4,7,10-TETRAAZACYCLODODECANE AND ITS DERIVATIVES | SCHERING AG (DE) | 2000-07-12 | — | — | EP | claimed |
| WO-1998050421-A1 | ANALGESIC PEPTIDOMIMETIC COMPOUNDS | ASTRA AKTIEBOLAG (PUBL) (SE) | 1998-11-12 | — | — | WO | claimed |
| US-5744616-A | CYCLOTETRAMERIZATION OF A BENZYLAZIRIDINE DERIVATIVE | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-04-28 | — | — | US | claimed |
| US-4522984-A | WITH E-CAPROLACTONE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1985-06-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085668-A1 | Diols formed by ring-opening of epoxies | EPHX2, OXER1, EPHX1 | EPHX1 3/4885TRPA1 2929/4885SRR 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.